Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Handfield

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Toxicology and Applied Pharmacology|April 30, 2019
Preclinical evaluation of the maximum tolerated dose and toxicokinetics of enteric-coated lantibiotic OG253 capsulesN V Rajeshkumar, Johan A Kers, Scott Moncrief, et al.
Plos Neglected Tropical Diseases|October 20, 2010
Identification of Leishmania proteins preferentially released in infected cells using change mediated antigen technology (CMAT)Peter E Kima, J Alfredo Bonilla, Eumin Cho, et al.
Infection and Immunity|April 9, 2008
Role of Porphyromonas gingivalis SerB in gingival epithelial cell cytoskeletal remodeling and cytokine productionYoshiaki Hasegawa, Gena D Tribble, Henry V Baker, et al.
Journal of Chemical Theory and Computation|December 7, 2021
Lipid II Binding and Transmembrane Properties of Various Antimicrobial LanthipeptidesRudramani Pokhrel, Nisha Bhattarai, Prabin Baral, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Pharmacological, Toxicological, and Dose Range Assessment of OG716, a Novel Lantibiotic for the Treatment of <i>Clostridium difficile</i>-Associated InfectionMark E Pulse, William J Weiss, Johan A Kers, et al.
BMC Microbiology|March 24, 2012
Identification of genes expressed in cultures of E. coli lysogens carrying the Shiga toxin-encoding prophage Φ24BLaura M Riley, Marta Veses-Garcia, Jeffrey D Hillman, et al.
Physical Chemistry Chemical Physics : PCCP|June 1, 2019
Molecular mechanisms of pore formation and membrane disruption by the antimicrobial lantibiotic peptide Mutacin 1140Rudramani Pokhrel, Nisha Bhattarai, Prabin Baral, et al.
Infection and Immunity|February 20, 2007
Gingival epithelial cell transcriptional responses to commensal and opportunistic oral microbial speciesYoshiaki Hasegawa, Jeffrey J Mans, Song Mao, et al.
Cellular Microbiology|December 25, 2004
In vivo induced antigen technology (IVIAT)Sean M Rollins, Amanda Peppercorn, Long Hang, et al.
Plos One|June 13, 2018
OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infectionsJohan A Kers, Anthony W DeFusco, Jae H Park, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Toxicology and Applied Pharmacology|April 30, 2019
Preclinical evaluation of the maximum tolerated dose and toxicokinetics of enteric-coated lantibiotic OG253 capsulesN V Rajeshkumar, Johan A Kers, Scott Moncrief, et al.
Plos Neglected Tropical Diseases|October 20, 2010
Identification of Leishmania proteins preferentially released in infected cells using change mediated antigen technology (CMAT)Peter E Kima, J Alfredo Bonilla, Eumin Cho, et al.
Infection and Immunity|April 9, 2008
Role of Porphyromonas gingivalis SerB in gingival epithelial cell cytoskeletal remodeling and cytokine productionYoshiaki Hasegawa, Gena D Tribble, Henry V Baker, et al.
Journal of Chemical Theory and Computation|December 7, 2021
Lipid II Binding and Transmembrane Properties of Various Antimicrobial LanthipeptidesRudramani Pokhrel, Nisha Bhattarai, Prabin Baral, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Pharmacological, Toxicological, and Dose Range Assessment of OG716, a Novel Lantibiotic for the Treatment of <i>Clostridium difficile</i>-Associated InfectionMark E Pulse, William J Weiss, Johan A Kers, et al.
BMC Microbiology|March 24, 2012
Identification of genes expressed in cultures of E. coli lysogens carrying the Shiga toxin-encoding prophage Φ24BLaura M Riley, Marta Veses-Garcia, Jeffrey D Hillman, et al.
Physical Chemistry Chemical Physics : PCCP|June 1, 2019
Molecular mechanisms of pore formation and membrane disruption by the antimicrobial lantibiotic peptide Mutacin 1140Rudramani Pokhrel, Nisha Bhattarai, Prabin Baral, et al.
Infection and Immunity|February 20, 2007
Gingival epithelial cell transcriptional responses to commensal and opportunistic oral microbial speciesYoshiaki Hasegawa, Jeffrey J Mans, Song Mao, et al.
Cellular Microbiology|December 25, 2004
In vivo induced antigen technology (IVIAT)Sean M Rollins, Amanda Peppercorn, Long Hang, et al.
Plos One|June 13, 2018
OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infectionsJohan A Kers, Anthony W DeFusco, Jae H Park, et al.
Pageof 4